diabetes mellitus type 2/edema

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 62 rezilta yo

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Diabetic macular edema (DME) causes significant visual loss in diabetic patients. About 20% and 40% of patients with Type 1 and Type 2 diabetes mellitus (DM), respectively, develop DME. One-third of diabetic patients who have had DM for more than twenty years will develop DME . Early impairment in

Arterial Composition and Cardiovascular Outcome in DIabeteS

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

PhD project description The arterial wall in patients with diabetes: Do changes in arterial basement membrane proteins predict future arterial disease? Are remodeling processes altered? Applicant: Anne-Sofie Faarvang Thorsen1, MD Main supervisor: Professor Lars Melholt Rasmussen1 Co-supervisors:

Effectiveness of Foot Exercise People With Type 2 Diabetes

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Purpose of our study investigation of the effects foot exercises in patients with type 2 diabetic and peripheral neuropathy. Excepted results: Routine treatment + foot exercises pain, flexibility, edema, muscle strength, sensation, quality of life we believe that there will be good progress in

The Sensitivity of Traditional Chinese Medical Diagnostic Tools for Diabetic Retinopathy Diabetic retinopathy-a Pilot Study

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

GLP-1 REceptor Agonists and Real World EvIdeNce

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Introduction. Glucagon-like peptide-1 receptor agonists (GLP-1RA) are prioritized as a second-line therapy for the treatment of type 2 diabetes (T2D), especially in patients with a history of cardiovascular disease (CVD) or when there is a need to avoid weight gain and hypoglycemia. Randomized

Effects of Fenofibrate Therapy in Diabetic Nephropathy

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In this single-centre, open label study, 300 adults with DN will be recruited over 3 years. Following screening and baseline metabolic evaluations, eligible subjects will be treated with fenofibrate for 30-days and re-assessed. 4.1 Study Visits and Procedures Subjects will have their written

Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

As part of the central nervous system (CNS), the retina shares key structural and functional features with the brain, making it a potential portal into a patient's medical future. Since the cerebral and retinal microvasculature are strikingly similar, the condition of retinal vasculature has been

Characterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Diabetic Retinopathy (DR) is a frequent complication of Diabetes Mellitus (DM) and is the main cause of vision loss in the working population in western countries. Several studies provided evidence that good diabetic control is important to prevent and delay disease progression, but while some

Shanghai Beixinjing Diabetic Eyes Study

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

PROMINENT-Eye Ancillary Study (Protocol AD)

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Screening For Diabetic Macular Edema Among Diabetic Patients Using Optical Coherence Tomography

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The worldwide prevalence of diabetic macular edema was reported as 6.81% among patients with diabetes. Other research reported that the 10-year incidence of diabetic macular edema was 14% in individuals with type 2 diabetes, and progression to diabetic macular edema occurred in 29% of individuals

Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This is a prospective, randomized, double-masked, multicenter, Phase I/II clinical study in which up to 40 eligible subjects with active Diabetic Macular Edema (DME) will be randomized to 1 of 2 treatment arms in a 1:1 ratio as follows: SF0166 low dose twice daily (BID) or SF0166 high dose BID. The

CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye